释放抗体的力量:为明天的治疗设计工程
Sagar1, Malemnganba Takhellambam1, Aditi Rattan1
1Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, Dhaula Kuan, New Delhi, India.
Advances in protein chemistry and structural biology
|May 18, 2024
概括
抗体工程通过创建用于治疗和诊断的专门蛋白质来增强宿主对疾病的防御能力. 先进的技术使大规模生产能够改善人类健康并对抗各种病原体.
科学领域:
- 免疫学和生物技术
- 专注于抗体在宿主防御中的关键作用和抗体工程的进步.
背景情况:
- 抗体是专门的蛋白质,对于对病原体的免疫防御至关重要.
- 感染引发了抗体的产生,将先天性和适应性免疫结合起来.
研究的目的:
- 探索抗体工程的多学科领域.
- 突出工程抗体在治疗,诊断和研究中的应用.
主要方法:
- 使用尖端技术,如混合体技术和转基因小鼠.
- 采用显示技术 (菌体,酵母体,核糖体) 和下一代测序用于抗体工程和生产.
主要成果:
- 工程抗体对于各种应用至关重要,包括治疗和诊断.
- 先进的方法促进了对人类有益的抗体的大规模生产.
结论:
- 抗体工程对于开发未来的治疗点具有显著的前景.
- 持续的研究对于使用基于抗体的策略来对抗各种疾病至关重要.
相关概念视频
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


